Gene · 6336
Papers2,467
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,467
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gastroesophageal reflux-induced cough: the positive feedback loop of microaspiration and neurogenic inflammation. | Ther Adv Respir Dis | 2026 | 41871964 | PubTator, text mining | PubMed |
| Alternative splicing in voltage-gated sodium channels: mechanisms, regulatory networks and therapeutic implications. | Ann Med | 2026 | 41869747 | PubTator, text mining | PubMed |
| Nav1.8 Variant I206M as a Latent Susceptibility Factor in Postaxotomy Ocular Pain. | Neurol Genet | 2026 | 41868096 | PubTator, text mining | PubMed |
| Nav1.8 mediates peripheral-to-central nociceptive transmission independently of central presynaptic mechanisms in human DRG-spinal cord circuits. | bioRxiv | 2026 | 41867732 | PubTator, text mining | PubMed |
| The Excelsatoxin A-Receptor TMEM233 Modulates Nav1.8. | FASEB J | 2026 | 41854608 | PubTator, text mining | PubMed |
| TGF-β and IL-4 + IL-13 induce neuroplasticity in an in vitro model of hPSC-derived sensory neurons. | Front Immunol | 2026 | 41853271 | PubTator, text mining | PubMed |
| Selective NaV1.8 Inhibition for Pain Management: Current Evidence and Future Potential of Suzetrigine. | Curr Pain Headache Rep | 2026 | 41842993 | PubTator, text mining | PubMed |
| Suzetrigine (VX-548) exhibits activity-dependent effects on human dorsal root ganglion neurons with differential pain etiology. | Pain | 2026 | 41800743 | PubTator, text mining | PubMed |
| Varicella Zoster Virus Infection: Clinical Features, Molecular Pathogenesis, Treatment, and Prevention. | MedComm (2020) | 2026 | 41799932 | PubTator, text mining | PubMed |
| Reviewing the Peripheral and Central Mechanisms of Visceral Hypersensitivity in Intestinal Disorders. | Int J Med Sci | 2026 | 41799760 | PubTator, text mining | PubMed |
| Suzetrigine (a NaV1.8 inhibitor) versus placebo for acute postoperative pain: A systematic review and meta-analysis of randomized controlled trials. | Medicine (Baltimore) | 2026 | 41790692 | PubTator, text mining | PubMed |
| Safety and efficacy of Suzetrigine (VX-548) for acute moderate to severe pain in adults; a systematic review and meta-analysis. | J Clin Anesth | 2026 | 41785614 | PubTator, text mining | PubMed |
| Targeting molecular pathways in neuropathic cancer pain: from mechanisms to novel therapeutics. | iScience | 2026 | 41782818 | PubTator, text mining | PubMed |
| Osteoarthritis: molecular pathogenesis and potential therapeutic options. | Signal Transduct Target Ther | 2026 | 41781374 | PubTator, text mining | PubMed |
| Resistivity method-based rock core orientation experimental protocol. | PLoS One | 2026 | 41770823 | PubTator, text mining | PubMed |
| Suzetrigine for Acute Pain in the Emergency Department: A First-in-Class NaV1.8 Blocker. | J Am Coll Emerg Physicians Open | 2026 | 41767204 | PubTator, text mining | PubMed |
| Alteplase and Angioedema: Can Clinical Exome Sequencing Redefine the Paradigm? | Life (Basel) | 2026 | 41752838 | PubTator, text mining | PubMed |
| Single-Dose Pharmacokinetic Assessment of TNX-102 SL (Cyclobenzaprine HCl Sublingual Tablets): Results From Randomized, Open-Label Studies in Healthy Volunteers. | Clin Pharmacol Drug Dev | 2026 | 41749492 | PubTator, text mining | PubMed |
| Exploring the Pain-Relieving Potential: Unveiling Antinociceptive Properties in Animal Venoms and Toxins. | Toxins (Basel) | 2026 | 41745735 | PubTator, text mining | PubMed |
| The Neuro-Bone Axis in Metastatic Progression: Innervation, Neuro-Immune-Osteoclast Crosstalk, and Therapeutic Opportunities. | Biology (Basel) | 2026 | 41744673 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6336/papers?page=4